David M. Berman - 17 Feb 2026 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Reporting relationship: HEAD OF R&D
Issuer ticker: IMCR
Reported as of: 17 Feb 2026
Net transaction value: -$192,968
SEC form: 4
Accepted by SEC: 19 Feb 2026, 17:00:12 UTC
Prior SEC filing: 08 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Lily Hepworth, Attorney-in-Fact

Key filing fact

David M. Berman filed Form 4 for Immunocore Holdings plc (IMCR) on 19 Feb 2026.

Key facts

This page summarizes David M. Berman's Form 4 filing for Immunocore Holdings plc (IMCR).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 19 Feb 2026, 17:00.

Change

Previous filing in this sequence was filed on 08 Dec 2025.
Current net transaction value: -$192,968.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001955244 Primary reporting owner

Berman David M

Relationship: HEAD OF R&D
Address: C/O IMMUNOCORE HOLDINGS PLC, 92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM
Signature: /s/ Lily Hepworth, Attorney-in-Fact
Signature date: 19 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMCR transaction

Ordinary Shares

Options Exercise

Transaction value: $0
Shares: +11,824
Change %
Price: $0.000000
Shares after: 11,824
Date: 17 Feb 2026
Ownership: Direct
Footnotes: F1

IMCR transaction

Ordinary Shares

Sale

Transaction value: $192,968
Shares: -5,965
Change %: -50%
Price: $32.35
Shares after: 5,859
Date: 18 Feb 2026
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMCR transaction Derivative

Restricted Share Units

Options Exercise

Transaction value: $0
Shares: -11,824
Change %: -25%
Price: $0.000000
Shares after: 35,473
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 11,824
Exercise price
Footnotes: F1, F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share.

Footnote F2

The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock units ("RSUs").

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.17 to $32.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

Each RSU represents a contingent right to receive one Ordinary Share.

Footnote F5

On February 17, 2025, the Reporting Person was granted 47,297 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date.